Stomach Cancer Clinical Trials

Find Stomach Cancer Clinical Trials Near You

Research on the Application of Fecal Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection in the Early Diagnosis and Screening of Gastric Cancer

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo fecal H. pylori gastric cancer susceptibility testing and complete the gastric cancer risk questionnaire.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: t
View:

• Age ≥40 years, male or female.

• No contraindications to endoscopy and able to cooperate with endoscopy.

• Patients must be able to fully understand the informed consent form and be able to sign the informed consent form in person.

Locations
Other Locations
China
People's Hospital of Tongling City
RECRUITING
Tongling
Contact Information
Primary
Dazhi Xu, PhD
xudzh@fudan.edu.cn
86-18121299796
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 15000
Related Therapeutic Areas
Sponsors
Leads: Fudan University

This content was sourced from clinicaltrials.gov